uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Roctavian
Application withdrawn
Human
Orphan medicine
Details
EMA number
EMEA/H/C/004749
ATC code
-
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Treatment of haemophilia A
MeSH:
Hemophilia A
Group:
Antihemorrhagics
Active substances
valoctocogene roxaparvovec
Marketing Authorisation Holder
BioMarin International Limited
MAH
Timeline
Filter by authority:
EMA
Status changed: Authorised → Application withdrawn
31 Jul 2026
status_changed
regulatory
Roctavian authorised
24 Aug 2022
authorised
regulatory
Roctavian | uMedical